This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Evidence is stacking up about the influence of cannabinoids on cardiovascular disease, and newer, synthetic options are binding even more tightly to the CB1 receptor, which could be harmful.
Medscape Medical News